Ceritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung Cancer

Clinical trial NCT02321501 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02321501
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

ALK Positive Locally Advanced Malignant Solid Neoplasm Metastatic Malignant Solid Neoplasm ROS1 Gene Rearrangement Stage IIIB Lung Non-Small Cell Cancer AJCC v7 Stage IV Lung Non-Small Cell Cancer AJCC v7

Start date: 2016-06-22
Primary completion: 2026-12-31
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.